These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2575569)

  • 1. SK&F 89124, a potent and selective agonist at prejunctional dopamine receptors.
    Hieble JP; Sulpizio AC; Sarau HM; Flaim KE; Blumberg AL; McCafferty JP; Zeid RL
    Fundam Clin Pharmacol; 1989; 3(6):621-42. PubMed ID: 2575569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinhibitory effects of SK&F 85174, a novel dopamine receptor agonist.
    Blumberg AL; Wilson JW; Hieble JP
    J Cardiovasc Pharmacol; 1985; 7(4):723-32. PubMed ID: 2410714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of selective dopamine receptor agonists in the rat and dog.
    Hieble JP; Owen DA; Harvey CA; Blumberg AL; Valocik RE; DeMarinis RM
    Clin Exp Hypertens A; 1987; 9(5-6):889-912. PubMed ID: 2887313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856.
    Hieble JP; Sulpizio AC; Edwards R; Chapman H; Young P; Roberts SP; Blackburn TP; Wood MD; Shah DH; Demarinis RM
    J Pharmacol Exp Ther; 1991 Nov; 259(2):643-52. PubMed ID: 1682482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors.
    Oriowo MA; Hieble JP; Ruffolo RR
    Pharmacology; 1991; 43(1):1-13. PubMed ID: 1683709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors.
    Hieble JP; Sulpizio AC; Nichols AJ; Willette RN; Ruffolo RR
    J Pharmacol Exp Ther; 1988 Nov; 247(2):645-52. PubMed ID: 2903236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
    Akers I; Coates J; Drew GM; Sullivan AT
    Br J Pharmacol; 1991 Apr; 102(4):943-9. PubMed ID: 1677300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone: a prejunctional dopamine receptor agonist.
    Gallagher G; Lavanchy PG; Webster CA; Wilson JW; Hieble JP; DeMarinis RM
    J Med Chem; 1985 Oct; 28(10):1533-6. PubMed ID: 4045928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral vascular and neuronal effects of dopamine receptor agonists. A comparison with receptor binding studies in rat striatum.
    Semeraro C; Ferrini R; Allievi L; Pocchiari F; Nicosia S; Casagrande C
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):539-46. PubMed ID: 1982561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor agonist activity of some 5-(2-aminoethyl)carbostyril derivatives.
    Kaiser C; Dandridge PA; Garvey E; Flaim KE; Zeid RL; Hieble JP
    J Med Chem; 1985 Dec; 28(12):1803-10. PubMed ID: 4068005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of presynaptic receptors in the cardiovascular actions of N,N-di-n-propyldopamine in the cat and dog.
    Massingham R; Dubocovich ML; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Oct; 314(1):17-28. PubMed ID: 7442823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
    Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic differentiation between pre- and postjunctional alpha 2-adrenoceptors by SK&F 104078.
    Ruffolo RR; Sulpizio AC; Nichols AJ; DeMarinis RM; Hieble JP
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):415-8. PubMed ID: 2893296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective alpha-2 adrenoceptor blockade by SK&F 86466: in vitro characterization of receptor selectivity.
    Hieble JP; DeMarinis RM; Fowler PJ; Matthews WD
    J Pharmacol Exp Ther; 1986 Jan; 236(1):90-6. PubMed ID: 2867217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA; Wardell JR; Sarau HM; Ridley PT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
    Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP
    J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DA1 receptor agonist fenoldopam (SK & F 82526) is also an alpha 2-adrenoceptor antagonist.
    Ohlstein EH; Zabko-Potapovich B; Berkowitz BA
    Eur J Pharmacol; 1985 Dec; 118(3):321-9. PubMed ID: 2867915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal dopamine receptors of the rabbit ear artery: pharmacological characterization of the receptor.
    Hieble JP; Nelson SH; Steinsland OS
    J Auton Pharmacol; 1985 Jun; 5(2):115-24. PubMed ID: 4019529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence for differences between pre- and postjunctional alpha 2-adrenoceptors in the periphery.
    Connaughton S; Docherty JR
    Br J Pharmacol; 1990 Jan; 99(1):97-102. PubMed ID: 1970496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-[2-hydroxy-5-[2-(methylamino)ethyl]phenyl]methanesulfonamide. A potent agonist which releases intracellular calcium by activation of alpha 1-adrenoceptors.
    DeMarinis RM; Lavanchy P; Hieble JP; Jim KF; Matthews WD
    J Med Chem; 1985 Feb; 28(2):245-8. PubMed ID: 2982020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.